Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluates the efficacy and safety of Inavolisib plus Phesgo versus placebo plus Phesgo in patients with PIK3CA-mutated HER2-positive locally adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inavolisib (Inavolisib)
• PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Breast Cancer | Phase 3 | Status: RECRUITING